COMPANY
Monon Bioventures LLC
NIH awards 5
- NIH award 1R43CA271914-01 FY2022: $399,314 awarded for that fiscal year; activity R43 (SBIR); PI TREBLEY, JOE; recipient as written: MONON BIOVENTURES, LLC, Indianapolis, IN. Off-the-shelf engineered NK cells to trea source ↗
- NIH award 5R44DK121594-03 FY2021: $504,770 awarded for that fiscal year; activity R44 (SBIR); PI HEIMAN, MARK LOUIS; recipient as written: MONON BIOVENTURES, LLC, Indianapolis, IN. Soluble, solution-stable phospho-gl source ↗
- NIH award 4R44DK121594-02 FY2020: $495,101 awarded for that fiscal year; activity R44 (SBIR); PI HEIMAN, MARK LOUIS; recipient as written: MONON BIOVENTURES, LLC, Indianapolis, IN. Soluble, solution-stable phospho-gl source ↗
- NIH award 1R44DK121594-01 FY2019: $298,152 awarded for that fiscal year; activity R44 (SBIR); PI HEIMAN, MARK LOUIS; recipient as written: MONON BIOVENTURES, LLC, Indianapolis, IN. Soluble, solution-stable phospho-gl source ↗
- NIH award 1R41GM122130-01A1 FY2017: $331,395 awarded for that fiscal year; activity R41 (STTR); PI BESNER, GAIL E; recipient as written: MONON BIOVENTURES, LLC, Indianapolis, IN. A Novel Probiotic Platform to Treat N source ↗